Page 6 - Lung Cancers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Jänne on the FDA Approval of Osimertinib Plus Chemotherapy in EGFR+ mNSCLC

Pasi A. Jänne, MD, PhD, discusses the FDA approval of osimertinib plus chemotherapy in patients with EGFR-mutant locally advanced or metastatic NSCLC.

Davidm livingstonChen huang centerLowe centerBelfer centerDana farber cancer instituteHarvard medical schoolThoracic oncologyApplied cancer scienceLung cancersPasia jänneFda approval of osimertinib plus chemotherapyPatients with egfr mutant locally advanced or metastatic nsclc

Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

University of iowaUnited statesUniversity of iowa health careJames byrneUniversity of iowa holden comprehensive cancer centerIowa health careIowa healthIowa holden comprehensive cancerLung cancersAdvanced science

Time is of the Essence for Lung Cancer: Wellstar Experts

The earlier a possible cancer in the lungs can be detected, the easier it may be to remove the cancer before it spreads.

Kathy dejosephWellstar health systemUs preventative services taskHealth systemBill mayfieldMayo clinicServices task forcesWellstar kennestone hospitalSpecialty teamsHealth effects of tobaccoLung cancerWellstar health systemWellstar kennestone hospitalMayo clinicT wellstar kennestone hospitalHill mayfield

Dr Jänne on the Investigation of RMC-6291 in KRAS G12C-Mutated Solid Tumors

Pasi A. Jänne, MD, PhD, discusses the mechanism of action of the novel KRAS G12C RAS(ON) inhibitor RMC-6291, which is being evaluating for the treatment of patients with KRAS-mutated solid tumors.

Harvard medical schoolBelfer centerChen huang centerLowe centerDana farber cancer instituteThoracic oncologyApplied cancer scienceLung cancersOnclive tv

Investigators Deliver Updates on Evolving Clinical Trials Evaluating ADCs in Lung Cancer

Melissa L. Johnson, MD, Terufumi Kato, MD, and Pasi A. Jänne, MD, PhD, present updates from the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer.

United statesDana farber cancer instituteIfinatamab deruxtecanMelissal johnsonTrastuzumab deruxtecanTerufumi katoHarvard medical schoolLowe centerChen huang centerSarah cannon research instituteCancer committee at tristar centennial medical centerBelfer centerInternational associationLung cancerCancer committeeTristar centennial medical center